SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

REM Sleep Behavior Disorder

Enter Course



Course Description

This program is worth up to 2.0 CME credits.

Neurologists frequently encounter patients who present with "dream enactment behavior" in the setting of the Rapid Eye Movement (REM) sleep behavior Disorder (RBD). Unfortunately, few neurologists have received formal training in sleep medicine to adequately recognize, evaluate and manage this unique cohort. Recent data reveals that RBD may be a biomarker of an evolving neurodegenerative disease and diagnoses is important to establish a risk and in some cases, confirm diagnosis.

The purpose of this program is to provide neurologists in practice with the knowledge needed to recognize, diagnose and treat RBD, appreciating both the clinical and scientific perspective of the disease, but more importantly, appreciate the psychosocial impact from a patient's perspective.

Up to 2.0 CME credits

Pricing

Members: FREE $39.00*
Nonmembers: $69.00

*Free access is limited to one course at a time for eligible members.

Learning Objectives

As a result of this program the learner will:

(1) Describe the pathophysiology associated with REM Sleep Behavior Disorder.

(2) Diagnose and manage REM Sleep Behavior Disorder.

(3) Counsel patients about the prognosis while considering the patient perspective.

Core Competencies

  • Patient Care
  • Interpersonal and Communication Skills
  • Professionalism
  • Medical Knowledge
  • Practice-Based Learning and Improvement
  • Systems-Based Practice

Date of Release

April 14, 2016

This module is eligible for CME credits for three years from the release date.

Confidentiality of Data

All material © American Academy of Neurology Institute unless otherwise indicated. All rights reserved.

See complete Terms of Use.

Faculty & Disclosures

ALON Y. AVIDAN, MD, MPH FAAN
Professor of Neurology
Director, UCLA Sleep Disorders Center
Director, UCLA Neurology Clinic
*Dr. Avidan has received personal compensation for activities with Xenoport, Merck, Vanda and Best Doctors.

Editor, NeuroLearn

A. GORDON SMITH, MD, FAAN
University of Utah Department of Neurology
Salt Lake City, Utah
*Dr. Smith has received personal compensation for activities with Allergan, Baxter Bioscience, Merz, Pfizer and NeurogesX as a consultant..

NeuroLearn Staff:

Minneapolis, Minnesota

Maureen Holtzman, Senior Manager, Education
*Ms. Holtzman has nothing to disclose.

Angela Elliott, Program Manager, Online Learning
*Ms. Elliott has nothing to disclose.

Robert Rook, Program Manager, Digital Education Resources
*Mr. Rook has nothing to disclose.

Susan Rodmyre, Senior Director, Education
*Ms. Rodmyre has nothing to disclose.

Kurt Wiersma, Senior Manager, Web Development
*Mr. Wiersma has nothing to disclose.

*Relationship Disclosure

Enter Course

MEMBER LOG IN

Forgot Password?